
Uplarafenib
CAS No. 1425485-87-5
Uplarafenib( —— )
Catalog No. M35714 CAS No. 1425485-87-5
Uplarafenib (B-Raf IN 10) is a potent BRAF inhibitor with an IC50 of 50-100 nM. B-Raf IN 10 exhibits antitumor activity that may influence cell proliferation and differentiation, making it suitable for studying solid tumors.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 132 | Get Quote |
![]() ![]() |
5MG | 202 | Get Quote |
![]() ![]() |
10MG | 297 | Get Quote |
![]() ![]() |
25MG | 610 | Get Quote |
![]() ![]() |
50MG | 917 | Get Quote |
![]() ![]() |
100MG | 1557 | Get Quote |
![]() ![]() |
500MG | 3132 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameUplarafenib
-
NoteResearch use only, not for human use.
-
Brief DescriptionUplarafenib (B-Raf IN 10) is a potent BRAF inhibitor with an IC50 of 50-100 nM. B-Raf IN 10 exhibits antitumor activity that may influence cell proliferation and differentiation, making it suitable for studying solid tumors.
-
DescriptionUplarafenib (B-Raf IN 10) (Compound C09) is a BRAF inhibitor with an IC50 between 50 and 100 nM. Uplarafenib shows antitumor activity.
-
In VitroUplarafenib (Compound C09) (1 μM) shows more than 89% inhibition against BRAF and BRAF V600E.Uplarafenib shows an IC50 between 50 and 100 nM against BRAF, less than 50 nM against BRAF V600E.Uplarafenib (72 h) inhibits A375 and SK-MEL-28 cells growth but not CHL-1 and SK-MEL-31 cells.Cell Viability Assay Cell Line:A375, SK-MEL-28, SK-MEL-31 and CHL-1 Concentration:Incubation Time:72 h Result:Showed inhibition with IC50s less than 500 nM against A375 and SK-MEL-28 cells, and showed no inhibition against CHL-1 and SK-MEL-31.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorRaf
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1425485-87-5
-
Formula Weight494.49
-
Molecular FormulaC22H21F3N4O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (202.23 mM; Ultrasonic (<60°C)
-
SMILESCCCS(=O)(=O)Nc1cc(F)c(F)c(C(=O)c2ccc3ncc(nc3c2)N2CCOCC2)c1F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yong-Liang Zhu, et al. Certain Chemical Entities, Compositions, and Methods. Patent US20130053384 A1.
molnova catalog



related products
-
Kobe0065
Kobe0065 is a novel and effective small-molecule compound inhibiting Ras–Raf interaction by SBDD.
-
GDC-0879
A potent and selective B-Raf kinase inhibitor with IC50 of 0.13 nM against purified B-Raf V600E and a cellular pERK IC50 of 63 nM in the MALME-3M cell line.
-
TBAP-001
TBAP-001 is a RAF kinase inhibitor, with an IC50 of 62 nM in BRAF V600E kinase assay and an IC50 of 18 nM in Cell-Based Phosho-ERK Assay.